MRNA
Moderna Inc
194.80$
+7.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -259.0% | – | – | – | -225.7% | – | – | – | -166.2% | – | – | |
| – | -18.9% | -82.2% | +13.9% | +26.8% | +15.4% | -35.0% | +46.2% | -8.8% | +28.8% | -11.9% | +6.8% | – | |
| – | +2.6% | +27.8% | +10.9% | +0.0% | -7.1% | +10.6% | +13.0% | -3.8% | -9.6% | -8.0% | +15.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +36.8% | -75.9% | -343.3% | – | +1,919.8% | -112.1% | – | – | – | -65.0% | -103.3% | – | |
| – | +57.1% | -10.9% | -7.1% | -17.0% | +245.7% | -75.7% | -97.6% | +1,000.0% | +18.2% | +59.0% | -40.3% | – | |
| – | -168.2% | – | +1,297.5% | -56.3% | -174.8% | – | -22.7% | +24.1% | -106.9% | +58.3% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -100.0% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -566.7% | – | -350.0% | -40.0% | – | -100.0% | – | – | |
| – | +87.9% | – | +142.9% | -67.6% | -127.3% | – | +125.0% | -111.1% | – | -97.0% | -17.6% | – | |
| – | – | – | – | -303.7% | – | -207.4% | – | – | – | -147.1% | – | – | |
| – | – | -394.8% | – | – | – | -484.2% | – | – | – | -175.9% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.